2018年拉斯克奖(Ⅱ)

doi:10.3969/j.issn.1006-7795.2018.05.030

摘要/Abstract

摘要： 北京时间2018年9月11日，拉斯克奖获奖者名单公布。基础医学奖授予美国洛克菲勒大学C.David Allis教授及加州大学洛杉矶分校Michael Grunstein教授，以表彰他们阐明组蛋白的化学修饰如何影响基因表达。临床医学研究奖授予原阿斯利康制药公司的John B.Glen，以表彰他发现并开发了世界上使用最为广泛的麻醉药物异丙酚。医学特殊成就奖授予耶鲁大学医学院Joan Argetsinger Steitz教授，以表彰她在RNA生物学中的重要贡献及对女性科学家工作的指导和有力支持。

关键词: 拉斯克奖, 组蛋白修饰, 异丙酚, 核糖核酸

Abstract: In September 11, 2018, the list of winners of the year's Lasker Awards were released. The Albert Lasker Basic Medical Research Award honors C. David Allis from Rockefeller University and Michael Grunstein from University of California, Los Angeles, for discoveries elucidating how gene expression is influenced by chemical modification of histones. The 2018 Lasker-DeBakey Clinical Medical Research Award honors John B. Glen (retired from AstraZeneca), who discovered and developed propofol, a chemical whose rapid action and freedom from residual effects have made it the most widely used agent for induction of anesthesia in patients throughout the world. The 2018 Lasker-Koshland Award for Special Achievement in Medical Science honors Joan Argetsinger Steitz from Yale University, for her discoveries in RNA biology, generous mentorship of budding scientists, and vigorous and passionate support of women in science.

Key words: Lasker Awards, histone modification, propofol, ribonucleic acid

魏昌伟, 岳云, 吴安石. 2018年拉斯克奖(Ⅱ)[J]. 首都医科大学学报, 2018, 39(5): 783-790.

Wei Changwei, Yue Yun, Wu Anshi. The 2018 Lasker Awards(Ⅱ)[J]. Journal of Capital Medical University, 2018, 39(5): 783-790.

参考文献

[1] Lasker M. Lasker Awards:Statement by the Albert and Mary Lasker Foundation[J]. JAMA,2015, 314(11):1182.
[2] Neill U S. From branch to bedside:Youyou Tu is awarded the 2011 Lasker-DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria[J]. J Clin Invest,2011,121(10):3768-3773.
[3] Williams C L. Michael Grunstein and David Allis receive the 2018 Lasker Basic Medical Research Award[J]. J Clin Invest, 2018, 128(10):4201-4203.
[4] Chen R, Kang R, Fan X G, et al. Release and activity of histone in diseases[J]. Cell Death Dis,2014, 5:e1370.
[5] Allfrey V G, Faulkner R, Mirsky A E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis[J]. Proc Natl Aca Sci USA, 1964, 51:786-794.
[6] Kornberg R D. Chromatin structure:a repeating unit of histones and DNA[J]. Science, 1974,184(4139):868-871.
[7] Jiang C, Pugh B F. Nucleosome positioning and gene regulation:advances through genomics[J]. Nat Rev Genet,2009,10(3):161-172.
[8] Greenberg M M. Abasic and oxidized abasic site reactivity in DNA:enzyme inhibition, cross-linking, and nucleosome catalyzed reactions[J]. Acc Chem Res,2014, 47(2):646-655.
[9] Han M, Grunstein M. Nucleosome loss activates yeast downstream promoters in vivo[J]. Cell, 1988, 55(6):1137-1145.
[10] Johnson L M, Kayne P S, Kahn E S, et al. Genetic evidence for an interaction between SIR3 and histone H4 in the repression of the silent mating loci in Saccharomyces cerevisiae[J]. Proc Natl Acad Sci USA, 1990, 87(16):6286-6290.
[11] Hecht A, Laroche T, Strahl-Bolsinger S, et al. Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins:a molecular model for the formation of heterochromatin in yeast[J]. Cell, 1995, 80(4):583-592.
[12] Kurdistani S K, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene expression[J]. Cell, 2004, 117(6):721-733.
[13] Brownell J E, Zhou J, Ranalli T, et al. Tetrahymena histone acetyltransferase A:a homolog to yeast Gcn5p linking histone acetylation to gene activation[J]. Cell, 1996, 84(6):843-851.
[14] Kuo M H, Brownell J E, Sobel R E, et al. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines[J]. Nature, 1996, 383(6597):269-272.
[15] Kuo M H, Zhou J, Jambeck P, et al. Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo[J]. Genes Dev, 1998, 12(5):627-639.
[16] Yoshida M, Kijima M, Akita M, et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A[J]. J Biol Chem, 1990, 265(28):17174-17179.
[17] Humphrey E L, Shamji A F, Bernstein B E, et al. Rpd3p relocation mediates a transcriptional response to rapamycin in yeast[J]. Chem Biol, 2004, 11(3):295-299.
[18] Dankoski E. The 2018 Lasker-DeBakey clinical medical research award recognizes john baird glen for the discovery of propofol[J]. J Clin Invest, 2018, pii:124375.
[19] Glen J B I. The Discovery and development of propofol anesthesia:the 2018 Lasker-DeBakey Clinical Medical Research Award[J]. JAMA, 2018,[Epub ahead of print].
[20] James R, Glen J B. Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents[J]. J Med Chem, 1980, 23(12):1350-1357.
[21] Glen J B. Animal studies of the anaesthetic activity of ICI 35868[J]. Br J Anaesth, 1980, 52(8):731-742.
[22] Glen J B, Hunter S C. Pharmacology of an emulsion formulation of ICI 35868[J]. Br J Anaesth, 1984, 56(6):617-626.
[23] Stokes D N, Peacock J E, Lewis R, et al. The Ohmeda 9000 syringe pump. The first of a new generation of syringe drivers[J]. Anaesthesia, 1990, 45(12):1062-1066.
[24] Glen J B. The development of ‘Diprifusor’:a TCI system for propofol[J]. Anaesthesia, 1998, 53 Suppl 1:13-21.
[25] Coetzee J F, Glen J B, Wium C A, et al. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets[J]. Anesthesiology, 1995, 82(6):1328-1345.
[26] Jackson S. RNA biologist Joan Steitz awarded the 2018 Lasker-Koshland Special Achievement Prize[J]. J Clin Invest, 2018,[Epub ahead of print].
[27] Steitz J A, Jakes K. How ribosomes select initiator regions in mRNA:base pair formation between the 3' terminus of 16S rRNA and the mRNA during initiation of protein synthesis in Escherichia coli[J]. Proc Natl Acad Sci USA, 1975, 72(12):4734-4738.
[28] Lerner M R, Steitz J A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus[J]. Proc Natl Acad Sci USA, 1979, 76(11):5495-5499.
[29] Lieberman J. Unveiling the RNA World[J]. N Engl J Med, 2018,379(13):1278-1280.
[30] Cazalla D, Yario T, Steitz J A. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA[J]. Science, 2010, 328(5985):1563-1566.
[31] Lieberman J. Tapping the RNA world for therapeutics[J]. Nat Struct Mol Biol, 2018, 25(5):357-364.